Possible...we get an major update Monday pre-market is my guess and it gives Linda and management the weekend to review, plan respond. Anyone's guess....
RedBarron and Sitain on this board have always stated how big Germany is to this international trial with 20 clinics and decision looming from PEI on Hospital Exemption for reimbursement for DCVax from German government is another significant catalyst as it will grab international attention. I agree 100% on this!
I like Linda's quiet confidence about how well DCVax is performing in all solid tumor cancers and my gut is telling me we are onto something big here now the immunotherapy is all over the news now and was on CNBC today.
Bosch isn't the only interesting participant either - for example, it will be interesting to see if Bross (FDA) gives any unusual/fresh commentary on the selection of primary endpoints in the panel discussion (same session as the NWBO case study)